Skip to main content
Porto
  • Home
  • News
  • Our Meetings
    • Monthly PMMNG Meetings
    • Steering Committee Meetings
  • Myeloma Events
    • Upcoming Events
    • Archived Myeloma Events
  • Our Members
  • Miles for Myeloma
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Myeloma Crowd: Using Selinexor in Today’s Myeloma Clinic with Paul Richardson, MD, Dana Farber Cancer Institute

Myeloma Crowd LogoWhat: Webcast transcript and audio (1:00:49)
When: Wednesday August 14, 2019
Where: Web

Tags
event
webcast
myeloma crowd
archived
treatment
Dr. Paul Richardson
selinexor
  • Read more about Myeloma Crowd: Using Selinexor in Today’s Myeloma Clinic with Paul Richardson, MD, Dana Farber Cancer Institute

CureTalks: Understanding the FDA approved New Drug, Selinexor and Its Use in Multiple Myeloma

CureTalks logoWhat: Webcast audio (60:33) and transcript
When: Wednesday September 4, 2019, 3:00 PM ET
Where: Web

Tags
event
archived
curetalks
audio
transcript
treatment
selinexor
Dr. Dan T. Vogl
  • Read more about CureTalks: Understanding the FDA approved New Drug, Selinexor and Its Use in Multiple Myeloma

Patient Power: Update on Developing Myeloma Treatments

Patient Power logoWhat: Webcast video (5:28)
When: Wednesday September 18, 2019
Where: Web

Tags
event
archived
patient power
treatment
clinical trials
selinexor
Dr. Elisabet Manasanch
Andrew Schorr
  • Read more about Patient Power: Update on Developing Myeloma Treatments

MMRF: New Drug Approval - What Does the Arrival of XPOVIO (selinexor) Mean for Multiple Myeloma Patients?

MMRF logoWhat: Webcast slides and audio (1:03:12)
When: Thursday October 17, 2019
Where: Web
Access slides

Tags
event
mmrf
archived
webcast
xpovio
selinexor
Dr. Paul Richardson
  • Read more about MMRF: New Drug Approval - What Does the Arrival of XPOVIO (selinexor) Mean for Multiple Myeloma Patients?

MMRF: Updates on New Drug Approvals and the Expanding Therapeutic Landscape in Multiple Myeloma

MMRF logoWhat:  Webcast
When: Tuesday, November 17, 2020 100 PM – 2:00 PM ET
Where: Web
View slides

Tags
event
archived
webcast
mmrf
treatment
newly approved drugs
blenrep
belantamab mafodotin
xpovio
selinexor
darzalex faspro
daratumumab and hyaluronidase
sarclisa
isatuximab
Dr. Joshua R. Richter
Dr. Nina Shah
  • Read more about MMRF: Updates on New Drug Approvals and the Expanding Therapeutic Landscape in Multiple Myeloma
Subscribe to selinexor